These three developmental-stage pharma stocks are attracting some of the smartest investors right now.
News & Analysis: Zymeworks Inc.
These developers of drugs for cancer, neurological conditions, and rare diseases may boost risk-taking investors' portfolios.
With Breast Cancer Awareness Month drawing to a close and the San Antonio Breast Cancer Symposium on the horizon, stay alert for breaking news from companies developing new treatments.
Doctors, researchers, and pharmaceutical experts will converge upon Barcelona to share the latest results in cancer research. Here is a run-down on three to watch.